Seeing Is Believing
UTRS is currently covered by 3 analysts with an average price target of $12.01. This is a potential upside of $11.6 (2829.27%) from yesterday's end of day stock price of $0.41.
Minerva Surgical's activity chart (see below) currently has 4 price targets and 7 ratings on display. The stock rating distribution of UTRS is 33.33% BUY and 66.67% SELL.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 81.5 days.
Highest price target for UTRS is $47, Lowest price target is $35, average price target is $12.01.
Most recent stock forecast was given by ROBBIE MARCUS from JPMORGAN on 10-Aug-2022. First documented stock forecast 16-Nov-2021.
Currently out of the existing stock ratings of UTRS, 1 are a BUY (33.33%), 2 are a SELL (66.67%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
280
1 years 8 months 15 days ago
0/1 (0%)
$90.2 (47.52%)
Buy
12
1 years 8 months 15 days ago
1/1 (100%)
$-23 (-65.71%)
153
Buy
7
$6.44 (1150.00%)
240
1 years 11 months 13 days ago
1/3 (33.33%)
$-28 (-80.00%)
173
Buy
14
$11 (366.67%)
15
2 years 1 months 16 days ago
0/2 (0%)
$7.2 (115.75%)
What is UTRS (Minerva Surgical) average time for price targets to be met?
Which analyst has the current highest performing score on UTRS (Minerva Surgical) with a proven track record?
Which analyst has the current lower performing score on UTRS (Minerva Surgical) with a proven track record?
Which analyst has the most public recommendations on UTRS (Minerva Surgical)?
Which analyst is the currently most bullish on UTRS (Minerva Surgical)?
Which analyst is the currently most reserved on UTRS (Minerva Surgical)?